Lanfear DE - Search Results

1

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.

Spertus JA, Birmingham MC, Nassif M, Damaraju CV, Abbate A, Butler J, Lanfear DE, Lingvay I, Kosiborod MN, Januzzi JL. Spertus JA, et al. Among authors: lanfear de. Nat Med. 2022 Apr;28(4):809-813. doi: 10.1038/s41591-022-01703-8. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228753 Free PMC article. Clinical Trial.

2

Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure.

Lanfear DE, Marsh S, Cresci S, Spertus JA, McLeod HL. Lanfear DE, et al. Pharmacogenomics. 2004 Jul;5(5):553-8. doi: 10.1517/14622416.5.5.553. Pharmacogenomics. 2004. PMID: 15212591

3

Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans.

Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL. Lanfear DE, et al. J Am Coll Cardiol. 2004 Jul 7;44(1):165-7. doi: 10.1016/j.jacc.2004.03.053. J Am Coll Cardiol. 2004. PMID: 15234427 Free article.

4

Beta2-adrenergic receptor genotype predicts survival: implications and future directions.

Lanfear DE, Spertus JA, McLeod HL. Lanfear DE, et al. J Cardiovasc Nurs. 2006 Nov-Dec;21(6):474-7. doi: 10.1097/00005082-200611000-00011. J Cardiovasc Nurs. 2006. PMID: 17293738 Review.

5

Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, Spertus JA, McLeod HL. Lanfear DE, et al. Am Heart J. 2007 Sep;154(3):561-6. doi: 10.1016/j.ahj.2007.04.059. Am Heart J. 2007. PMID: 17719307

6

Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization.

Lanfear DE, Peterson EL, Campbell J, Phatak H, Wu D, Wells K, Spertus JA, Williams LK. Lanfear DE, et al. Am J Cardiol. 2011 Jan;107(1):74-8. doi: 10.1016/j.amjcard.2010.08.045. Am J Cardiol. 2011. PMID: 21146690 Free PMC article.

7

Factors influencing patient willingness to participate in genetic research after a myocardial infarction.

Lanfear DE, Jones PG, Cresci S, Tang F, Rathore SS, Spertus JA. Lanfear DE, et al. Genome Med. 2011 Jun 15;3(6):39. doi: 10.1186/gm255. Genome Med. 2011. PMID: 21676259 Free PMC article.

8

Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.

Lanfear DE, Hrobowski TN, Peterson EL, Wells KE, Swadia TV, Spertus JA, Williams LK. Lanfear DE, et al. Circ Heart Fail. 2012 Mar 1;5(2):202-8. doi: 10.1161/CIRCHEARTFAILURE.111.965780. Epub 2012 Jan 19. Circ Heart Fail. 2012. PMID: 22260944 Free PMC article.

9

Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.

Cresci S, Dorn GW 2nd, Jones PG, Beitelshees AL, Li AY, Lenzini PA, Province MA, Spertus JA, Lanfear DE. Cresci S, et al. Among authors: lanfear de. J Am Coll Cardiol. 2012 Sep 4;60(10):898-907. doi: 10.1016/j.jacc.2012.02.051. Epub 2012 Jun 13. J Am Coll Cardiol. 2012. PMID: 22703928 Free PMC article.

10

Comparison of β-blocker effectiveness in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction.

El-Refai M, Peterson EL, Wells K, Swadia T, Sabbah HN, Spertus JA, Williams LK, Lanfear DE. El-Refai M, et al. Among authors: lanfear de. J Card Fail. 2013 Feb;19(2):73-9. doi: 10.1016/j.cardfail.2012.11.011. J Card Fail. 2013. PMID: 23384631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters